Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Mar 6.
Published in final edited form as: J Agric Food Chem. 2013 Feb 22;61(9):10.1021/jf304445p. doi: 10.1021/jf304445p

Dynamic Residual Complexity of the Isoliquiritigenin-Liquiritigenin Interconversion During Bioassay

Charlotte Simmler 1, Atieh Hajirahimkhan 1, David C Lankin 1, Judy L Bolton 1, Tristesse Jones 1, Djaja D Soejarto 1, Shao-Nong Chen 1, Guido F Pauli 1,*
PMCID: PMC3728173  NIHMSID: NIHMS449452  PMID: 23427769

Abstract

Bioactive components in food plants can undergo dynamic processes that involve multiple chemical species. For example, 2′-hydroxychalcones can readily isomerize into flavanones. Although chemically well documented, this reaction has barely been explored in the context of cell-based assays. The present time-resolved study fills this gap by investigating the isomerization of isoliquiritigenin (a 2′-hydroxychalcone) and liquiritigenin (a flavanone) in two culture media (DMEM and RPMI) with and without MCF-7 cells, using HPLC-DAD-ESI/APCI-MS for analysis. Both compounds isomerized and epimerized under all investigated biological conditions, leading to mixtures of isoliquiritigenin and R/S-liquiritigenin, with 19.6% R enantiomeric excess. Consequently, all three species can potentially modulate the biological responses. This exemplifies dynamic residual complexity and demonstrates how both non-chiral reactions and enantiomeric discrimination can occur in bioassay media, with or without cells. The findings highlight the importance of controlling in situ chemical reactivity, influenced by biological systems when evaluating the mode of action of bioactives.

Keywords: bioassay, epimerization, isoliquiritigenin, isomerization, liquiritigenin, residual complexity

INTRODUCTION

The chalcone isoliquiritigenin (2′, 4, 4′-Trihydroxychalcone) is biosynthetically and chemically related to the flavanone liquiritigenin (4′, 7-Dihydroxyflavanone). Both of them are found in numerous edible plant species primarily belonging to the Fabaceae13 or Amaryllidaceae families,4 but are also found in the Asparagaceae5 and Bignonaceae6 families. Despite their wide distribution, these two polyphenols have been mainly studied as bio-active constituents of Glycyrrhiza species (licorice, Fabaceae).7,8 From a biosynthetic perspective, isoliquiritigenin (LigC for Liquiritigenin Chalcone, see discussion on nomenclature in Supporting Information, S5) is not only the precursor and isomer of liquiritigenin (LigF for Liquiritigenin Flavanone), but also of many other flavonoids, formed as part of the phenylpropanoid pathway.9 At the early stage of flavonoid biosynthesis, chalcone isomerase (CHI) promotes the conversion of 2′-hydroxychalcones, such as LigC, into stereochemically defined 2-S flavanones. During the enzymatic isomerization, the ionized chalcone is folded into a chiral conformation through interaction with the amino acid side-chains in the CHI active site, which ensures high enantioselectivity of the flavanone production.10,11 From a chemical perspective, the isomerization of 2′-hydroxychalcones has been described as occurring spontaneously in protic solvents to form racemic flavanones. The chemical mechanism sustaining the isomerization of 2′-hydroxychalcones, in solvents and non-biological media, has been studied since 1975 and has already received considerable attention.1219 The cyclization of 2′-hydroxychalcones occurs through the initial deprotonation of the 2′-hydroxyl function and the subsequent formation of a 2′-oxyanion for the intra-molecular Michael addition on the α-β unsaturated double bond. This mechanism depends on the pH of the aqueous solution and has been demonstrated to be affected by the nature of the α-substituent of the chalcone (Figure 1).12,13 At neutral and lower acidic pH, 2′-hydroxychalcones are unstable and undergo rapid cyclization into flavanones.14,15 Under basic conditions, the flavanone isomers can undergo a reversible opening of their C-ring leading to their corresponding chalcones.16,17 In aqueous solution, this interconversion between chalcone and flavanone results in the racemization of optically active flavanones.16,18 Representing a thermodynamic reaction, the rates of isomerization and racemization are influenced by temperature.15,19 Thus, LigC and LigF are not only biosynthetically related, but also chemically interchangeable.

Figure 1.

Figure 1

Overview of the Chalcone-Flavanone Isomerization under Biosynthetic and Chemical Conditions. Flavanone biosynthesis involves stereochemically defined isomerization of 2′-hydroxychalcones catalyzed by chalcone isomerase. Non-enzymatic isomerization of 2′-hydroxychalcones-flavanones depends on the pH of the medium. In acidic solution, 2′-hydroxychalcones such as LigC fully isomerize into flavanones such as LigF. Under basic conditions, flavanones are unstable and produce 2′-hydroxychalcone through opening of the Cring. In neutral conditions, such as in physiological environments or cell culture media, the isomerization reactions occur in both directions, establishing a pH-dependent equilibrium of all potential species.

Interestingly, the chemical conditions promoting this isomerization closely match the conditions of cell-based assays, where the cells are cultured in aqueous medium (protic solvent), at buffered and physiological pH (around 7.4), and at a slightly elevated temperature of 37 °C. Under these “biological” conditions, isomerization of 2′-hydroxychalcones such as LigC is very likely to occur. Consequently, it is reasonable to hypothesize that LigF is produced in the culture medium during bioassays, and potentially contributes to the biological response. Such a LigC–LigF interconversion process would exemplify dynamic residual complexity (DRC), which is the result of the chemical instability or reactivity of a test compound, and can explain variations in biological responses that are observed over time.20

This basic hypothesis is supported by previous studies which have shown that LigC and LigF have closely related biological activities. For example, both compounds have been reported to exhibit estrogenic2123 anti-inflammatory,24,25 anti-cancer,6,2639 hepato-40,41 and neuro-protective42,43 properties (Supporting Information S2). In cases where the biological effects of both LigC and LigF have been directly compared side-by-side, LigC has been shown to exhibit better activity than LigF.6,21,25 In an effort to define their phytoestrogen potential, Miksicek et al. compared the estrogenic potency of LigC and LigF, under identical experimental conditions using a 1μM final concentration, and found that LigC displayed better estrogenic properties than LigF in competitive estrogen receptor (ER) binding and Chloramphenicol Acetyltransferase (CAT) enzyme assays on transfected HeLa and COS-7 cells.21 In two different studies, LigF has been reported to be a selective ER-β agonist on transfected U2OS and HeLa cells,22 while LigC exhibited agonist activities on both ERs (α/β) associated with a modulation of MCF-7 cells growth through ERα dependent pathways, and in a dose-dependent fashion.23 Recently, Feldman et al. demonstrated that LigC exhibited better anti-bacterial activity than LigF against various oral pathogens and also showed better anti-inflammatory property through the inhibition of the NF-κB pathway.25 However, the majority of the cell-based studies, reported up to now, have evaluated the biological properties of either LigC or LigF independently, rather than in parallel. This limits the confidence with which we can compare the biological properties of the two compounds by reference to the literature. While, Boumendjel et al. have highlighted the importance of the possible isomerization during cell-based assays with regard to the anti-cancer potential of chalcones,44 this reaction has not been monitored in situ and confirmed to occur during cell-based assays.

Herein, we report on the evaluation and characterization of the isomerization of LigC and LigF at 37 °C, pH ~7.4, in two widely used mammalian cell culture media, DMEM/F12 (Dulbecco’s Modified Eagle Medium), and RPMI 1640 (Roswell Park Memorial Institute Medium). The study was performed both in the presence and absence of cultured MCF-7 cells, each over the period of 4 days. The MCF-7 cell line employed in the studies is an epithelial cancer cell line derived from a breast adenocarcinoma and represents one of the most commonly used estrogen receptor positive breast cancer lines in biomedical research. Both LigF and LigC have displayed estrogenic activity in MCF-7 cells.2123 Considering that the chirality of some flavonoids (e.g., flavanones, flavanols, isoflavans) is rarely addressed in biological experiments, the present study aimed at defining the stereochemical stability of isolated S-LigF under the chosen bioassay conditions. For this purpose, time-resolved studies of the dynamic isomerization of LigC and LigF were monitored by HPLC with PDA and DUIS-MS under chiral and non-chiral conditions using a parallel protocol with Chiralpak® IA and Shimadzu C18 columns, respectively.

One objective of this study was to probe the influence of bioassay conditions including the culture media (enriched buffered aqueous media), temperature, time of incubation and presence of cells, on the isomerization and racemization of chalcones and flavanones. Another goal was to demonstrate the occurrence of biochemical discrimination between LigF enantiomers by comparison of experiments in media with and without the presence of cultured cells. The experiments cover several aspects ranging from the analysis of dynamic isomerization to the evaluation of LigF epimerization under cell-based bioassay conditions. Overall, the study was designed to gain a better understanding of the inevitable chemical processes that underlie any biological test result when dealing with chemically unstable 2′-hydroxychalcones and their flavanone isomers.

MATERIALS AND METHODS

General Experimental Procedures

The following instruments were used to obtain physical data: circular dichroism (CD) spectra were acquired on a Jasco J 715 polarimeter (l = 1 cm); HPLC and LC-MS analyses were carried out on a Shimadzu model LCMS-2020 instrument (Dual Ionization mode DUIS: Electrospray (ESI) and Atmospheric Pressure Chemical Ionization (APCI)), representing an integrated system with a DAD detector (Semi-Micro Flowcell, Diode Array Detector, Shimadzu SPD-M20A) on a Shimadzu C18 (4.6 × 5.0 mm, 5 μm, cat: 220- 91394-00) or a Diacel Chiralpak® IA (4.6 × 250 mm, 5 μm) column. DUIS-Mass Spectrometry acquisition parameters set as follows: probe voltage positive ionization mode: 4.5 kV, negative ionization mode: −4.5 kV, detector voltage: 1.2 kV, nebulizing gas flow rate: 1.5 L/min, drying gas flow rate: 10 L/min, DL temperature: 300 °C, heater temperature: 400 °C. The auto Sampler temperature was set at 4 °C and the column oven temperature was set at 40 °C. Post-run data analyses were done with the Shimadzu LabSolution software package. The Shimadzu C18 column was eluted at 0.6 mL/min with a gradient composed from H2O 0.1% formic acid (A) and ACN 0.1% formic acid (B) as follows: 5% to 57% B in 18 min, 57% to 98% B in 7 min, and hold at 98% B for 3 min. The Chiralpak® IA column was eluted isocratically with 55% ACN (0.1% formic acid) in a reverse phase mode or with n-hexane/ethanol gradient from 85 to 70% n-hexane in a normal phase mode, both at a flow rate of 0.7 mL/min. Countercurrent Separation (CCS) was carried out on a hydrodynamic centrifugal coil instrument (TBE-300B, Shanghai Tauto Biotech Co., Ltd.) integrated with the Cherry-One automated CCS system (Cherry Instruments, Chicago, IL.). Samples were dried using a Thermo-Fischer Savant SC250 EXP speed vacuum equipped with a RVT4104 refrigerator vapor trap. An EchoTherm CO30 Column Chiller-Heater (Torrey Pines Scientific, Inc., CA) was used to perform the defined temperature experiments.

Reagents

All chemicals and reagents including dimethylsulfoxide (DMSO) and HPLC-grade solvents were obtained from Fisher-Scientific (Hanover Park, IL) or Sigma-Aldrich (St. Louis, MO). All media for cell culture were purchased from Invitrogen (Grand Island, NY). Fetal Bovine Serum (FBS) was purchased from Atlanta Biologicals (Norcross, GA). The adsorbents HW-40 F and LH-20, used for LigC and LigF isolation were purchased from Tosoh Bioscience (King of Prussia, PA) and Sigma-Aldrich, respectively. For the preparation of LC calibration curves, LigF and LigC reference standards were purchased from Indofine Chemical Company Inc. (Hillsborough, NJ) and ChromaDex (Irvine, CA), respectively. A reference standard of 4′-hydroxyflavanone was used as an internal standard for LC-MS analyses and was also obtained from Indofine.

Plant Material and Extraction

Dried roots of G. uralensis Fisch. ex DC. were purchased from a local supplier (Chicago, IL). The plant material (voucher code: BC 624) was identified through a series of macroscopic, and microscopic analyses as well as DNA authentication, comparing it to a voucher specimen from the Field Museum (Chicago, IL, voucher no. 2174544). The powdered roots (998 g) were exhaustively extracted by percolation with MeOH at room temperature (weight/volume ratio: 1/20). Freeze-drying yielded 269 g of crude extract, representing 27% (w/w) of the powdered roots. The extract was stored at −20 °C prior to any chemical or biological analysis. A major portion of the crude extract (242 g) was dissolved in water/MeOH (80/20 v/v) and submitted to successive liquid/liquid partition with solvents of increasing polarity to yield five partitions: petroleum ether (22 g), CHCl3 (8.5 g), EtOAc (14.2 g), n-BuOH (27.5 g), and water (73 g).

Isolation and Purification of Liquiritigenin (LigF) and Isoliquiritigenin (LigC)

LigF and LigC were isolated from the CHCl3 partition of G. uralensis, after 2 steps of Medium and Low Pressure Liquid Chromatography (MPLC, LPLC) using HW-40 F (100% MeOH, 2.5 mL/min) and Sephadex LH-20 (100% MeOH, 1 mL/min). The final purification of LigC and LigF was achieved by CCS (Cherry-One coupled to Tauto 300 mL), using a HEMWat 0 (Hexane/EtOAc/MeOH/Water, 5:5:5:5) solvent system with the lower phase being mobile. The rotation speed was 800 rpm, the flow rate 2 mL/min, the injection volume 3 mL, and the stationary phase retention Sf 0.5. The K value of LigF (40 mg yield) and LigC (11 mg yield) in HEMWat 0 was determined to be 0.78 and 1.33, according to the retention volume, under these conditions. Compound identity and purity were assessed by means of qHNMR and MS analyses (Supporting Information, S3 and S4). Chiral analysis of LigF (40 μM in ethanol) by CD polarimetry was in accordance with previously published data.45,46 The enantiomeric purity of LigF was further determined by chiral chromatography with UV detection at 275 nm using an n-hexane-ethanol gradient from 85% to 70% n-hexane in normal phase mode on a Chiralpak® IA column.

Isomerization Study in Cell-free Culture Media

Solutions of LigC and LigF were prepared in DMSO freshly and immediately prior to their dilution in both DMEM and RPMI (final concentration 3 mM, 100 μM, 5 μM), which were supplemented with 1% glutamax-1, 1% NEAA (Non-Essential Amino Acids), and 0.05% insulin. DMEM and RPMI were additionally supplemented with 10% and 5% of heat-inactivated FBS, respectively. DMSO alone diluted in RPMI and DMEM (0.1% v/v final) was used as a blank. Each of the LigC, LigF and blank DMSO solutions were distributed in different vials and incubated at 37 °C. Samples diluted in PBS (Phosphate Buffered Serum) were used as controls. The influence of the temperature on the isomerization rate was also measured in PBS (100 μM final concentration) by keeping the samples in a thermostat at a programmed temperature (0, 15, 23, or 37 °C). Samples were collected every 2 h during 12 h, then twice a day for another three days. All samples were immediately partitioned with three volumes of EtOAc and the organic layer separated and dried in a speed vacuum concentrator for 2 h at 0 °C. At T0 LigC and LigF were diluted in the media, which had been kept at the desired temperature, and were directly extracted with EtOAc without further incubation. The pH was checked for each time point using pH strips (Whatman®, Panpeha, Sigma-Aldrich, St Louis). Experiments were done in triplicate. Dried samples were diluted in 200 μL of MeOH-HPLC grade and centrifuged (2 min, 1400 rpm) prior to HPLC-DAD-MS analysis.

Cell Culture Conditions

The MCF-7 cell line was purchased from American Tissue Culture Collection (Manassas, VA). MCF-7 cells were grown in RPMI 1640 media containing 1% glutamax-1, 1% NEAA, 0.05% insulin, and 5% heat-inactivated FBS. Two days prior to treating the cells, the medium was replaced with phenol red-free RPMI 1640 medium containing charcoal/dextran-stripped FBS with acetone-washed activated charcoal (100 mg/mL) at 4 °C for 30 min and centrifuged at 4000 rpm for 15 min at 4 °C. At 24 h prior to their treatment, cells were plated in 6 well-plates (4.6 × 10−6 cells/mL) in phenol red-free RPMI 1640 supplemented with 5% heat-inactivated FBS, 1% glutamax-1, 1% NEAAs, and 0.05% insulin.

Isomerization Study in the Bioassay Conditions with MCF-7 Cells

MCF-7 cells were treated with either LigC or LigF at 5 μM final concentration (0.1% v/v DMSO) after 24 h incubation in the 6 well-plates at 37 °C (5% CO2). Under these experimental conditions, neither LigC nor LigF were cytotoxic. During the first 12 h, the treated cells and culture media were collected every two hours, then once a day for the following three days. As described above, all samples were extracted by three volumes of EtOAc and dried in vacuo for 2 h at 0 °C. The cells were washed in PBS, treated with trypsin (5 min, 37 °C), and lysed in cold distilled water via two freezing (−80 °C)/thawing (room temperature) cycles. The cell content was extracted with EtOAc according to the same protocol used for the media. Experiments were done in duplicate. All dried samples were diluted in 200 μL of HPLC grade MeOH, 10 μL of the internal standard solution (4′-hydroxyflavanone at 40 μg/mL) was added, and the mixture was centrifuged (2 min, 1400 rpm) prior to HPLC-DUIS-MS analysis.

Chromatographic Analysis by HPLC-DAD-MS

Samples were analyzed according to the LC conditions described above. The retention times (tR) of LigF and LigC were 8.39 min and 13.38 min, respectively, with the Shimadzu C18 column. With the Chiralpak® IA column, R-LigF, S-LigF and LigC exhibited tR of 6.71 min, 7.48 min, and 8.59 min, respectively. Selected Ion Monitoring (SIM) in both positive ([M+H] + m/z = 257) and negative ionization ([M-H] m/z = 255) modes was chosen for MS data acquisition (see general procedure). For quantitative analysis, the area under the curve (AUC) for both LigC and LigF were taken at 310 nm (maximum specific wavelength for both chalcones and flavanones) of the UV chromatograms, as well as determined from the MS chromatograms obtained in the negative ionization mode. In order to determine the relative abundance of each isomer at the different time points, the sum of LigF and LigC concentrations was normalized to 100%. The same normalization was applied to the determination of the ratio of each LigF enantiomer [100 = [R-LigF] +[S-LigF]] and to the evaluation of enantiomeric excess (ee). The regression equations used for the calculation of LigC and LigF concentrations (in mg/mL) were: AUC310nm = 4.106 × [LigC] +7070.5, r2 = 0.9959 and AUC m/z =255 = 2.108 × [LigC] +462929, r2 = 0.9861 for LigC, AUC310nm = 3.106 × [LigF] +302.62, r2 = 0.9999 and AUC m/z =255 =1.108 × [LigF] +276223, r2 = 0.9945 for LigF (where [LigF] or [LigC] are the concentration of LigC or LigF in mg/mL (Supporting Information S6).

Statistics

Quantitative data represent mean ± standard deviation of independent experiments. Statistical comparison of results was made using analysis by Student’s-t test. Differences were considered significant (*) for p < 0.05.

RESULTS

Characterization of Enantiomeric Purity of Liquiritigenin

LigC and LigF were isolated from the CHCl3 partition of G. uralensis after two steps of MPLC and one final CCS step using the HEMWat 0 solvent system.47 The identity and purity of both polyphenols was monitored by qHNMR and MS analysis (Supporting Information, S3-S4). LigF stereochemistry and enantiomeric purity was defined successively by CD polarimetry and chiral chromatography. The CD spectra of flavanones with S configuration at C-2 exhibit a positive Cotton effect in the n→π* UV absorption band at 330–320 nm, and a negative Cotton effect in the π→π* absorption band with the 270–290 nm maximum.45 The CD spectrum obtained for LigF (40 μM, in ethanol) was consistent with previously reported data, confirming the S configuration at C-2 (Figure 2).46 Additionally, in order to study the time-resolved racemization of S-LigF; its enantiomeric purity was analyzed by chiral chromatography. For this purpose, a Chiralpak® IA column was used in normal phase mode with a gradient of n-hexane–ethanol, and the separated LigF enantiomers were detected at 275 nm. The chromatogram revealed that isolated LigF contained 11% of R- (tR = 21 min) vs. 89% of S-enantiomer (tR = 29 min). The enantiomeric identity and ratio were determined by CD polarimetry of each enantiomer and measurement of their areas under the curve (AUCs) at 275 nm.

Figure 2.

Figure 2

Absolute Configuration and Enantiomeric Purity of Isolated LigF. Chiral analysis of LigF, isolated from Glycyrrhiza uralensis, was performed on a Chiralpak® IA column with normal phase elution using a n-hexane-ethanol gradient. Enantiomers were detected at 275 nm. The R-LigF enantiomer was eluted at 21 min and the S-LigF enantiomer at 29 min. Evidently, the measured CD spectrum of isolated LigF was generated by the ee of S-LigF (89% S-LigF –11% R-LigF = 78% ee).

Isomerization in the Culture Media without Cultured Cells

In a first set of analyses, the isomerization of LigC and LigF was characterized in the absence of cultured cells, thus excluding the potential influence of cellular absorption and metabolism. The isomerization reactions were studied in two widely used culture media, RPMI 1640 and DMEM/F12, over 4 days and at 37 °C. The data obtained in these culture media were compared to those acquired in PBS. Each culture medium, in contrast to the PBS, was supplemented with 5% (for RPMI) to 10% (for DMEM) heat-inactivated FBS, 1% glutamax-1, 1% NEAAs, and 0.05% insulin. Therefore, the supplemented media contained a series of chiral molecules mostly in the form of the FBS proteins and their constituent L-amino acids. Three different final concentrations (5 μM, 100 μM, and 3 mM) of either LigF or LigC were tested. At regular intervals, samples were taken and extracted with EtOAc to separate the flavonoids from the unwanted proteins and other medium constituents. At T0, LigC and LigF were added to the media, which had been kept at 37 °C, and were directly extracted with EtOAc without further incubation. After evaporation and dissolution in MeOH, the samples were analyzed by chiral HPLC using a detection at 310 nm. The AUCs of LigC and LigF were used to calculate their concentration and final ratio in the analyzed samples. No isomerization was observed to occur during the HPLC analysis, as indicated by the UV-MS chromatogram of freshly prepared LigF and LigC solution in MeOH (Supporting Information, S4). During all the experiments, the pH of each medium remained around 7.4 (Figure 3). At 37 °C, the isomerization reaction of LigC began immediately and reached a steady-state after 48 h of incubation in all media, indicating that under those conditions the isomerization came to a low energy state. The final equilibrium, characterizing this isomerization in both culture media, was defined by a ratio of 10.4 ± 4.0% LigC to 89.6 ± 4.0% LigF. When the study was initiated with the flavanone, LigF, at 37 °C, the equilibrium was achieved within 10 h and defined by the same LigC/LigF ratio, confirming the reversible interconversion between the two compounds. Identical results were obtained regardless of media (DMEM, RPMI, PBS) and concentrations of LigF or LigC tested (data not shown).

Figure 3.

Figure 3

Time-Resolved Study of LigC and LigF Isomerization in Culture Media Without Cells. Panels A and B represent the relative abundance of each isomer present in the media at 37 °C over a period of 4 days, leading to the final equilibrium of LigF and LigC (C). When the isomerization study started with LigC (A) a steady state was reached in 48 h and characterized by a ratio of 89.6 ± 4% LigF for 10.4 ± 4% of LigC (C). When the isomerization study started with LigF (B), the steady state was reached in 10 h and characterized by a ratio of 91.2 ± 2.5% LigF to 8.8 ± 2.5% of LigC. The relative abundance of each compound was calculated according to their concentration in both culture media. Experiments were done in triplicate. No significant differences were observed for the ratio of enantiomers calculated at the equilibrium of both reactions.

At physiological pH, the isomerization reaction is a unimolecular reaction defined by either the intra-molecular cyclization of the 2′-hydroxychalcone, or by opening of the C-ring of the flavanone. Both reactions are initiated by the presence of free protons in the aqueous media. Moreover, the observed chalcone-flavanone interconversion in the media emphasizes the dynamic instability of the flavanone ring. This observation strongly suggests the occurrence of an epimerization-racemization of the optically active S-LigF, following a Wessely-Moser rearrangement.48 Interestingly, in both culture media, the isomerization of LigC did not lead to a racemic solution of LigF but to an enantiomeric mixture characterized by a ratio of 53.2 ± 1.7% R- to 36.4 ± 0.9% S-LigF (R-LigF ee = 17.2 ± 4.6%) after 24 h at 37 °C (Figure 4A and D). In contrast, racemization of LigF was observed within 6 h of incubation. The epimerization reaction also favored the production of the R-LigF enantiomer, with an ee of 7.4 ± 2.3% observed after 10 h of incubation in both RPMI and DMEM media but not in PBS (Figure 4B and D, Supporting Information S8). This indicates that the chiral environment of the culture medium induces asymmetric ring closure of the flavanone, leading to the production of R-LigF in excess. Moreover, this asymmetric induction was more important during LigC isomerization than LigF epimerization. Under the conditions of the bioassay, where samples are highly diluted in the culture media, the cyclization of LigC and the epimerization of LigF can be defined as either a zero or a first order reaction, until both reactions slow-down and reach the steady-state (Supporting Information S7). According to the rate constant (keq) for the equation of a zero order reaction (Figure 4C, equations (1) and (2)), the LigF epimerization was about twice as fast as the LigC isomerization during the first 8 h of incubation. The half-life of the isomerization reaction of LigC, defined as the time needed to isomerize 50% of LigC (or until only 50% LigC remained), was calculated as t1/2 = 16.50 h (equation 2), whereas for LigF epimerization, t1/2 = 6.30 h represented the time needed for the racemization of 50% S-LigF (equation 1). The isomerization of LigC was observed to be a slower reaction compared to the epimerization of LigF. As such, LigC isomerization could enable a better chiral interaction with the culture medium, thus, leading to a greater ee. The enantiomeric interconversion of flavanones through the production of an intermediate chalcone has been already demonstrated to occur for other flavanones such as naringenin and its glycosides, especially during maturation of plant material.49,50 The present study demonstrates that for LigF this interconversion also occurs during the cell-based assay. Considering the stereochemical instability of LigF, it will be difficult, or in many instances, practically impossible to evaluate the true biological activity of a defined pure LigF enantiomer under the conditions of cell-based assays at 37 °C, especially when the final results require 12 to 24 h of incubation.

Figure 4.

Figure 4

Stereochemical Discrimination of LigF Enantiomers During the Isomerization of LigC and the Epimerization of LigF in the Culture Media Without Cells. A and B represent the relative abundance of each isomer (LigC, R- and S-LigF) in the two media at 37 °C over a period of 4 days. When the isomerization study started with LigC (A), a significant ee of R-LigF at 17.2 ± 4.6% was observed and remained stable between 48 and 96 h. LigF, characterized by an er = 89:11 (S:R) at T0 (B), epimerized rapidly to yield a near racemic solution within 6 h of incubation. A slight ee of R-LigF at 7.4 ± 2.3% was observed after 10 h. The rate constant keq in the equations (C) demonstrate that LigF epimerization (keq = 6.10) was faster than LigC isomerization (keq = 2.96). The histogram D compares the relative abundance of R-LigF, S-LigF and LigC at the reaction equilibrium. Experiments were done in triplicate.

Influence of Temperature

As the isomerization/racemization of LigC and LigF was shown to occur in the culture media at 37 °C, at stable and physiological pH, the next step was to evaluate the influence of temperature on these reactions. Therefore, the reaction characteristics were studied at three additional temperatures (0–4, 15 and 23 °C) using PBS at pH ~7.4 (Figure 5). As expected, the isomerization and racemization rates of both compounds were reduced at 23 °C and more so at 15 °C, compared to 37 °C. A steady isomerization state was reached after 96 h when conducting the experiments at these temperatures. A racemic solution of LigF was obtained after 24 h at 23 °C, compared to only 6 h at 37 °C (Figure 5B). However, at temperatures between 0 °C and 4 °C, no isomerization or racemization was observed. At physiological pH ~7.4, in aqueous solution, in accordance with thermodynamic laws (Arrhenius equation), thermal energy can be regarded as the principal factor affecting both isomerization and racemization rates.15, 19 From a practical perspective, these results indicate that the bio-activity of single LigF enantiomers could potentially be evaluated if the experiments are performed at 4 °C, or in less than 10 h at 15 °C.

Figure 5.

Figure 5

Temperature Influence on the Rates of Isomerization and Racemization. The relative abundance of LigC (A) and LigF enantiomers (B) is represented at different time-points, and for the four temperatures (0, 15, 24, 37 °C), in PBS at pH ~7.4 (100 μM final concentration). Experiments were done in triplicate. At 0–4 °C, no isomerization of LigC (A) or racemization of LigF (B) was observed. However, at 15 °C LigF racemization (B) was reached after 4 days of incubation, compared to 6 h at 37 °C. In an aqueous solution of physiologic pH, the rates of LigC isomerization (A) and LigF racemization (B) increased with rising temperatures.

In conclusion, this time-resolved study carried out under bioassay conditions without cells allowed a detailed characterization of the isomerization of LigC, which led to a final equilibrium of three species defined by 10.4 ± 4.0% of LigC, 53.2 ± 1.7% of R-LigF and 36.4 ± 9% of S-LigF after 2 days of incubation at 37 °C and pH ~7.4 (Figure 4A). Epimerization of LigF led to a steady-state equilibrium after 10 h of incubation, characterized by a final composition of 8.8 ± 2.5% of LigC, 49.2 ± 1.0% of R-LigF and 42 ± 0.5% of S-LigF (Figure 4B). Finally, when starting with either pure LigF or LigC, three chemical entities were formed within 6 h of incubation. Their respective quantities were shown to change as a function of time and temperature.

Isomerization and Epimerization in the Presence of MCF-7 Cells

The second major aim was to determine whether the isomerization and epimerization reactions were affected by cellular absorption and metabolism. For this purpose, a time-resolved study was conducted in the presence of cultured MCF-7 cells, following the same incubation conditions previously described. It was hypothesized that a regular cellular uptake of LigC and LigF from the culture medium would affect the isomerization rate. The MCF-7 cells were treated with 5 μM of either LigC or LigF and incubated at 37 °C, with 5% CO2, and over a period of 4 days. At this concentration, neither compound was cytotoxic. Samples from both the cells and the medium were taken at regular intervals, every 2 h during the first 12 h, then once a day until 4 days. At each time point, the extracts of the medium (RPMI 1640) and the intra-cellular contents were analyzed by DUIS LC-MS using SIM detection (m/z = 255) in negative ionization mode. The concentrations of LigC and R/S-LigF were determined for each sample using a standard calibration curve for each compound.

The decrease in LigC concentration in RPMI was more pronounced than that of LigF, indicating that freshly introduced LigC gets absorbed more rapidly by the cells (Figure 6A and B). This observation can only be partially explained by the difference in polarity/lipophilicity between the two compounds. Because of its α-β unsaturation, the chalcone tends to be more lipophilic than its flavanone counterparts, enhancing its passage through the cell membrane. Regardless whether LigF or LigC were independently administered to the test system, the MCF-7 cells absorbed more than 50% of each compound within 24 h. Most of the cellular absorption occurred between 10 and 48 h of incubation, as indicated by the analysis of the cellular content (Figure 6C and D). During the course of the entire experiment, concurrent isomerization of LigC and epimerization of LigF were observed. The relative contents of LigC and its isomer, LigF, calculated from their respective concentration in RPMI, were identical during the first 10 h of incubation with or without cultured cells (Figure 6E). These percentages were clearly different from 10 to 48 h, indicating that the isomerization kinetics of LigC were affected by the cellular uptake of both LigC and LigF. For example, at 24 h, the LigC/LigF ratio produced by isomerization in the medium of cultured MCF-7 cells was 60/40, compared to a 35/65 ratio without cells. In this experiment, the cellular uptake/metabolism slowed down the isomerization of LigC between 10 and 48 h. After that, the cellular uptake seemed to be less pronounced, thus enabling the isomerization to become predominant and convert the remaining compounds in the medium. However, no significant differences were observed for the isomerization kinetics of LigF obtained with or without cells (Figure 6F). The racemization of LigF did also occur within 6 h of incubation in the presence of cultured cells (Figure 7A). Therefore, this reaction was not influenced by the cellular uptake, suggesting that LigF epimerization was faster than cellular absorption. Within 10 h, the stereochemical instability of LigF led to an R-LigF ee of 19.6 ± 4.0%, representing a value that was significantly higher compared to that obtained in the absence of cultured cells (ee = 7.4 ± 2.3%). This ee did not change within 48 h (Figure 7B). The same type of ee was observed between 10 and 48 h, regardless whether the cells were treated with 5 μM of LigC or LigF. Consequently, the R-LigF ee observed in RPMI in the presence of MCF-7 cells indicated that S-LigF was preferably absorbed by the cells, leading to an increased concentration of R-LigF in the medium (Figure 7C). The consideration of stereochemical instability of LigF and biological discrimination of its enantiomers could offer new insights in the interpretation of future bioassay results.

Figure 6.

Figure 6

Isomerization of LigC and Epimerization of LigF in the Presence of MCF-7 Cells. Panels A and C represent the concentration (μM) of LigC and its isomer produced in the RPMI medium, and found inside the MCF-7 cells, respectively. Panels B and D represent the concentration (μM) of LigF and its isomer produced in the RPMI medium, and found inside the MCF-7 cells, respectively. Cells were initially treated with 5 μM of LigC or LigF. Data presented in the presence of cells were obtained from two independent and representative experiments. The isomerization of LigC occurred within 96 h of incubation in the presence of MCF-7 cells, as indicated by the increase in LigF concentration (A and C). However, the rate of isomerization was reduced from 10 to 48 h of incubation in the presence of cells (E), indicating that the cellular uptake slowed down the isomerization of LigC. The production of LigC from LigF occurred in RPMI medium with cells (B and D). The kinetics of LigF isomerization was not significantly different from those obtained without cells (D), indicating that the isomerization/epimerization reaction of LigF was not influenced by cellular uptake or metabolism.

Figure 7.

Figure 7

Biological Discrimination of LigF Enantiomers RPMI in the Presence of MCF-7 cells. Panel A presents the concentration (μM) of R- and S-LigF and its isomer LigC produced in RPMI medium with MCF-7 cells, initially treated with 5 μM of LigF (er 89:11 S/R-LigF). Panel B represents the relative abundance of R-LigF enantiomer, normalized to 100% for the sum of both LigF enantiomers remaining in RPMI. Data presented were obtained from independent and representative experiments. A significant R ee was observed in the medium of MCF-7 cells between 10 and 48 h. The chiral LC-MS chromatograms (C) of the solutions extracted from RPMI medium and MCF-7 cells after 24 h illustrate the R-LigF ee observed in RPMI, compared to the S-LigF ee determined inside the cells.

In conclusion, isomerization of LigC and LigF occurs in the presence of cells and leads to a significant production of both isomers in the culture media, but also inside the cells. The isomerization rate of LigC was altered by the cellular uptake, but could also be affected by the cellular density of the medium, the metabolic status of the cultured cells, and the type of investigated cell line. However, according to the present results, it is more likely that the epimerization of LigF will not be affected by these cellular factors, but will rather occur rapidly in any bioassay conducted at 37 °C. Finally, because the three chemical entities are produced within 6 h of incubation, in the culture media, the administered compound no longer represents a pure agent, but is a residually complex mixture. As such, the resulting equilibrium cocktail could unfold more complex actions, e.g. through synergistic, additive or antagonistic activities, to yield the finally observed biological test result. Accordingly, it does not appear to be feasible to truly separate the biological activity of LigC from those of its isomers in cell-based assays at 37 °C.

DISCUSSION

The present work studies the isomerization of LigC and the epimerization of LigF under cell-based assay conditions, and highlights the complex dynamic equilibrium between 2′-hydroxychalcones and flavanones. The dynamic interconversion of LigF and LigC as well as the biochemical discrimination of LigF enantiomers in cell-based assay conditions is demonstrated for the first time. The evolution of the LigC/LigF ratio as well as S-/R-LigF ee was shown to be a function of time, at a given temperature and physiological pH. The interconversion between LigC, LigF, and the LigF enantiomers represents an important example of DRC.20,51 The three chemical entities are generated in the culture medium, simultaneously and in various proportions, and can modulate the ultimate biological response (Figure 8). Therefore, the observed bioactivity is a function of all the experimental conditions that affect the expression of the 2′-hydroxychalcone/flavanones equilibrium. These analyses shed a new light on the chemical conversion and complexity that underlies the biological response of what is widely considered due to “pure” LigC or LigF.

Figure 8.

Figure 8

The Actual Expression of the Dynamic Residual Complexity (DRC) of 2′-Hydroxychalcone/Flavanone is a Function of the Individual Bioassay Conditions. Under cell-based assay conditions (37 °C, pH ~7.4), the isomerization of 2′-hydroxychalcones (C) and the epimerization of flavanones (F) are principally a function of the incubation time and influenced by the chiral characteristic of the culture medium. The kinetics of isomerization and the ratio of flavanone enantiomers produced are affected by cellular factors, defined by the cell line chosen for the bioassay and its metabolic status. In Phosphate Buffer Serum (PBS), isomerization and epimerization reactions are influenced by both temperature and incubation time. Consequently, the observed biological responses are convolutes of the bioassay conditions and the dynamic interconversion between 2′-hydroxychalcones and flavanones.

While epimerization of flavanones and isomerization of 2′-hydroxychalcones are considered relatively simple chemical reactions, it is important to note that these processes involve multiple unstable but potentially bioactive intermediates, which also must be present in the culture media, such as cis/trans 2′-hydroxychalcone or the chalconate anion.

Additionally, the present results highlight the importance of considering cell culture media as chiral environments which are able to chemically interact with compounds under investigation. During plant biosynthesis, the enantioselective production of S-flavanone is a consequence of the interaction between chalconate ions and the chiral amino-acids of the CHI enzymatic core.10,11 This reaction mechanism was recently modeled by Hintermann and Dittmer to chemically and selectively produce S-flavanone.52 In a comparable way, the interaction of LigC with the amino acids and proteins of the culture media contribute to its asymmetric cyclisation and lead to an ee. This reaction could occur through ion-pairing processes with chiral agents such as proteins and amino acids present in the culture media.

Many comparative biological studies have assigned LigC a greater activity than LigF when the respective compound was introduced in the bioassay (Supporting Information S2). However, when taking into consideration the DRC beginning with LigC, it is entirely possible that the measured bioactivity might not be solely attributed to LigC, but could be attributed to either combined (additive, synergistic, and/or antagonistic) effects between LigC and its isomers (R/S-LigF) and/or its metabolites produced during the experiments.28,51 As the bioactivity of LigC can be linked to the bioactivity of its flavanone isomers, future studies are warranted that compare LigC and LigF side-by-side, so as to provide a better interpretation of their in vitro biological activities. For an even more accurate interpretation, it would be of interest to determine the LigC and LigF ratio in the culture medium at the time of the readings. However, if the biological experiments can be performed at 0–4 °C, or at 15 °C in less than 10 h, or at 37 °C in less than 1 h, it should be possible to compare the biological activity of the individual pure species of LigC, R-LigF and S-LigF. Under these bioassay conditions, observed effects such as receptor binding can be attributed with much higher confidence to the compound introduced initially.

The stereoselectivity of the biological environment in cell-based assay for LigF enantiomers is another important consideration, as stereochemical discrimination affects not only the pharmacodynamic but also the pharmacokinetic (PK) parameters of LigF. This is illustrated by the study of Li et al., who demonstrated a predominant renal excretion of the S-LigF enantiomer after ingestion of herbal remedies.53 Recently, Sayre et al. have shown that various PK parameters are clearly distinct for the enantiomers.54 Although the PK analysis of LigF enantiomers has already received some attention, their potentially different pharmacodynamics have not been evaluated so far. Therefore, in future in vitro cell-based assays involving these compounds, the biochemical discrimination of LigF enantiomers should be considered.

Insights derived from the present study can likely be applied to other structurally related 2′-hydroxychalcones and their isomers. As suggested by previous chemical studies, the substitution pattern, especially in the A ring of 2′-hydroxychalcones and their flavanone isomers, will strongly influence their rate of isomerization and potential epimerization,15,19,55 but will also affect their cellular uptake.56 Consequently, the kinetics of their isomerization in cell culture medium at 37 °C, as well as the final steady-state equilibrium of the reaction would be different for each individual 2′-hydroxychalcone-flavanone pair. Further studies comparing isomerization and racemization under bioassay conditions of various structurally different 2′-hydroxychalcones and flavanone isomers would allow establishment of structure isomerization relationships as a form of DRC, and will be required to gain a better understanding of the biological activities of these related compounds.

The present results also emphasize the necessity of evaluating the chemical stability of compounds intended for biological evaluation in an aqueous medium at 37 °C. The choice of bioassay-like conditions for the study of chemical stability would provide a better identification and understanding of the lack or presence of RC of the actual bioactive compounds, and could expedite discovery of the potential existence of pro-drugs.

Because the interconversion between LigC/LigF and LigF enantiomers begins rapidly in buffered aqueous media at 37 °C, it is conceivable that the same reaction occurs during aqueous extraction of any plant material that contains 2′-hydroxychalcones, such as Glycyrrhiza sp. and Medicago sativa. The occurrence of isomerization during extraction can potentially affect both the relative ratio between 2′-hydroxychalcones and flavanones and the corresponding flavanone racemization or epimerization.49,57 Finally, variation in the dynamic LigC-LigF isomerization-epimerization could also occur throughout plant life including biosynthesis and maturation, during the plant extraction process, as part of the in vitro bioassay, and during in vivo metabolism and elimination (gastrointestinal digestions,57 liver metabolism, and renal excretion). The resulting various levels of RC make the correlation of chalcone/flavanone chemistry and biological activity an even more intricate task and requires a solid knowledge of the residually complex chalcone/flavanone equilibrium.

Supplementary Material

1_si_001

Acknowledgments

The authors thank Dr. James B. McAlpine for his helpful comments and advice during the preparation of this manuscript. CS particularly thanks Dr. Dejan Nikoli for his support and insightful comments on MS analysis. CS is also grateful to Dr. José G. Napolitano for his generous NMR explanations. The authors are also thankful to Dr. B. Ramirez for his support in the NMR facility and the use of the Jasco polarimeter at the UIC Center for Structural Biology (CSB). Thanks are expressed to the Field Museum for access to the Glycyrrhiza collections for this research.

Funding: This research was supported by NCCAM and ODS of the NIH through grant P50AT000155. The construction and instrumentation of the UIC CSB NMR facility was funded by NIGMS grant P41 GM068944.

ABBREVIATIONS USED

CCS

Counter Current Separation

CD

Circular Dichroism

CHI

Chalcone Isomerase

DMEM

Dulbecco’s Modified Eagle Medium

DRC

Dynamic Residual Complexity

DUIS

Dual Ion Source (ESI and APCI)

ee

Enantiomeric Excess

er

Enantiomeric Ratio

ER

Estrogen Receptor

FBS

Fetal Bovine serum

keq

rate constant of the kinetics equation

LC

Liquid Chromatography

LigC

Isoliquiritigenin

LigF

Liquiritigenin

NEAAs

Non-Essential Amino Acids

PBS

Phosphate Buffer Serum

t1/2

Half-life of the kinetics equation

RC

Residual Complexity

RPMI

Roswell Park Memorial Institute Medium

Footnotes

Residual Complexity and Bioactivity, Part 18 (see S1)

SUPPORTING INFORMATION DESCRIPTION

A comparative table on the most frequently reported biological activities of LigF and LigC, the qHNMR and MS data obtained for isolated LigF and LigC, the UV and MS calibration curves used for the quantitation of these isomers in the different extracted solutions, as well as the comparative LC-MS chromatograms obtained at different time points of the kinetic study. This material is available free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Hong YH, Wang S, Hsu C, Lin BF, Kuo YH, Huang C. Phytoestrogenic compounds in alfalfa sprout (Medicago sativa) beyond coumestrol. J Agric Food Chem. 2011;59:131–137. doi: 10.1021/jf102997p. [DOI] [PubMed] [Google Scholar]
  • 2.Liu RX, Wang Q, Guo HZ, Li L, Bi KS, Guo DA. Simultaneous determination of 10 major flavonoids in Dalbergia odorifera by high performance liquid chromatography. J Pharm Biomed Anal. 2005;39:469–476. doi: 10.1016/j.jpba.2005.04.007. [DOI] [PubMed] [Google Scholar]
  • 3.Shimamura M, Akashi T, Sakurai N, Suzuki H, Saito K, Shibata D, Ayabe SI, Aoki T. 2-Hydroxyisoflavanone dehydratase is a critical determinant of isoflavone productivity in hairy root cultures of Lotus japonicus. Plant Cell Physiol. 2007;48:1652– 1657. doi: 10.1093/pcp/pcm125. [DOI] [PubMed] [Google Scholar]
  • 4.Baba M, Ohmura M, Kishi N. Saponins isolated from Allium chinense G. Don and antitumor-promoting activities of isoliquiritigenin and laxogenin from the same drug. Biol Pharm Bull. 2000;23:660–662. doi: 10.1248/bpb.23.660. [DOI] [PubMed] [Google Scholar]
  • 5.Wang YF, Mu TH, Chen JJ, Luo SD. Studies on chemical constituents from the root of Polygonatum kingianum. Zhongguo Zhong Yao Za Zhi. 2003;28:524–527. [PubMed] [Google Scholar]
  • 6.Khamsan S, Liawruangrath S, Teerawutkulrag A, Pyne SG, Garson MJ, Liawruangrath B. The isolation of bioactive flavonoids from Jacaranda obtusifolia H. B. K. ssp. rhombifolia (G. F. W. Meijer) Gentry. Acta Pharm. 2012;62:181–190. doi: 10.2478/v10007-012-0014-1. [DOI] [PubMed] [Google Scholar]
  • 7.Chen XJ, Zhao J, Meng Q, Li SP, Wang YT. Simultaneous determination of five flavonoids in licorice using pressurized liquid extraction and capillary electrochromatography coupled with peak suppression diode array detection. J Chromatogr A. 2009;1216:7329–7335. doi: 10.1016/j.chroma.2009.08.034. [DOI] [PubMed] [Google Scholar]
  • 8.Nomura T, Fukai T, Akiyama T. Chemistry of phenolic compounds of licorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities. Pure Appl Chem. 2002;74:1199–1206. [Google Scholar]
  • 9.Dixon RA, Pasinetti GM. Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience. Plant Physiol. 2010;154:453–457. doi: 10.1104/pp.110.161430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jez JM, Noel JP. Reaction mechanism of chalcone isomerase. pH dependence, diffusion control, and product binding differences. J Biol Chem. 2002;277:1361–1369. doi: 10.1074/jbc.M109224200. [DOI] [PubMed] [Google Scholar]
  • 11.Jez JM, Bowman ME, Richard A, Noel JP. Structure and mechanism of the evolutionarily unique plant enzyme chalcone isomerase. Nat Struct Biol. 2000;7:786–791. doi: 10.1038/79025. [DOI] [PubMed] [Google Scholar]
  • 12.Ferreira D, Brandt EV, Volsteedt du RF, Roux DG. Parameters regulating the α-and β-Cyclization of Chalcones. J Chem Soc, Perkin Trans. 1975;1:1437–1446. [Google Scholar]
  • 13.Furlong JJP, Ferretti FH, Pappano NB, Debattista NB, Borkowski EJ, Kavka J. Kinetics of chalcone-flavanone isomerization. I. 2′,4′-Dihydroxychalcone/7-hydroxyflavanone. Anales de Quimica, Serie C: Quimica Organica y Bioquimica. 1985;81:199–204. [Google Scholar]
  • 14.Cisak A, Mielczarek C. Practical and Theoretical Aspects of Flavanone-Chalcone isomerisations. J Chem Soc, Perkin Trans 2: Physical Organic Chemistry (1972–1999) 1992:1603–1607. [Google Scholar]
  • 15.Furlong JJP. Cyclization of Substituted 2′-Hydroxychalcones to Flavanones. Solvent and Isotope effects. J Chem Soc, Perkin Trans. 1988;2:1213–1217. [Google Scholar]
  • 16.Nudelman NS, Furlong JJP. Conversion of flavanones into chalcones in alkaline medium. Kinetic and spectroscopic studies. J Physic Org Chem. 1991;4:263–270. [Google Scholar]
  • 17.Andújar SA, Filippa MA, Ferretti FH, Blanco SE. Isomerization of 4′-methoxy-flavanone in alkaline medium. Determination of the enolate formation constant. J Mol Struc-THEOCHEM. 2003;636:157–166. [Google Scholar]
  • 18.Yamin LJ, Blanco SE, Luco JM, Ferretti FH. Theoretical study of cyclization of 2′-hydroxychalcone. J Mol Struc-THEOCHEM. 1997;390:209–215. [Google Scholar]
  • 19.Miles CO, Main L. Kinetics and Mechanism of the Cyclisation of 2′, 6′-Dihydroxychalcone and Derivatives. J Chem Soc, Perkin Trans. 1989;2:1623–1632. [Google Scholar]
  • 20.Chen SN, Lankin DC, Chadwick LR, Jaki BU, Pauli GF. Dynamic residual complexity of natural products by qHNMR: solution stability of desmethylxanthohumol. Planta Med. 2009;75:757–762. doi: 10.1055/s-0028-1112209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Miksicek J. Occurring Plant Flavonoids Have Estrogenic Activity. Mol Pharmacol. 1993;44:37–43. [PubMed] [Google Scholar]
  • 22.Mersereau JE, Levy N, Staub RE, Baggett S, Zogovic T, Zogric T, Chow S, Ricke WA, Tagliaferri M, Cohen I, Bjeldanes LF, Leitman DC. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol Cell Endocrinol. 2008;283:49–57. doi: 10.1016/j.mce.2007.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Maggiolini M, Statti G, Vivacqua A, Gabriele S, Rago V, Loizzo M, Menichini F, Amdò S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol. 2002;82:315–322. doi: 10.1016/s0960-0760(02)00230-3. [DOI] [PubMed] [Google Scholar]
  • 24.Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, Kim SG, Kim SC. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF- kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol. 2008;154:165–173. doi: 10.1038/bjp.2008.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Feldman M, Santos J, Grenier D. Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. J Nat Prod. 2011;74:1862–1867. doi: 10.1021/np200174h. [DOI] [PubMed] [Google Scholar]
  • 26.Prasad S, Phromnoi K, Yadav VR, Chaturvedi MM, Aggarwal BB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med. 2010;76:1044–1063. doi: 10.1055/s-0030-1250111. [DOI] [PubMed] [Google Scholar]
  • 27.Zhou M, Higo H. Inhibition of hepatoma 22 tumor by liquiritigenin. Phytother Res. 2010;833:827–833. doi: 10.1002/ptr.3024. [DOI] [PubMed] [Google Scholar]
  • 28.Cuendet M, Guo J, Luo Y, Chen S, Oteham CP, Moon RC, van Breemen RB, Marler LE, Pezzuto JM. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. Cancer Prev Res. 2010;3:221–232. doi: 10.1158/1940-6207.CAPR-09-0049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Liu Y, Xie S, Wang Y, Luo K, Wang Y, Cai Y. Liquiritigenin inhibits tumor growth and vascularization in a mouse model of HeLa cells. Molecules. 2012;17:7206– 7216. doi: 10.3390/molecules17067206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Liu C, Wang Y, Xie S, Zhou Y, Ren X, Li X, Cai Y. Liquiritigenin induces mitochondria-mediated apoptosis via cytochrome c release and caspases activation in HeLa Cells. Phytother Res. 2011;25:277–283. doi: 10.1002/ptr.3259. [DOI] [PubMed] [Google Scholar]
  • 31.Wang Y, Xie S, Liu C, Wu Y, Liu Y, Cai Y. Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells. Nutr Cancer. 2012;64:627–634. doi: 10.1080/01635581.2012.675617. [DOI] [PubMed] [Google Scholar]
  • 32.Zhang S, Zhou Y, Liu Y, Cai Y. Effect of liquiritigenin, a flavanone existed from Radix glycyrrhizae on pro-apoptotic in SMMC-7721 cells. Food Chemical Toxicol. 2009;47:693–701. doi: 10.1016/j.fct.2008.12.015. [DOI] [PubMed] [Google Scholar]
  • 33.Hsu YL, Chia CC, Chen PJ, Huang SE, Huang SC, Kuo PL. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells. Mol Nutr Food Res. 2009;53:826–835. doi: 10.1002/mnfr.200800288. [DOI] [PubMed] [Google Scholar]
  • 34.Takahashi T, Baba M, Nishino H, Okuyama T. Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells. Cancer Lett. 2006;231:319–325. doi: 10.1016/j.canlet.2005.02.025. [DOI] [PubMed] [Google Scholar]
  • 35.Yoshida T, Horinaka M, Takara M, Tsuchihashi M, Mukai N, Wakada M, Sakai T. Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells. Environ Health Prev Med. 2008;13:281–287. doi: 10.1007/s12199-008-0041-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chen G, Hu X, Zhang W, Xu N, Wang FQ, Jia J, Zhang WF, Sun ZJ, Zhao YF. Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells. Apoptosis. 2012;17:90–101. doi: 10.1007/s10495-011-0658-1. [DOI] [PubMed] [Google Scholar]
  • 37.Zhang X, Yeung ED, Wang J, Panzhinskiy EE, Tong C, Li W, Li J. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin Exp Pharmacol Physiol. 2010;37:841–847. doi: 10.1111/j.1440-1681.2010.05395.x. [DOI] [PubMed] [Google Scholar]
  • 38.Jung JI, Lim SS, Choi HJ, Cho HJ, Shin HK, Kim EJ, Chung WY, Park KK, Park JHY. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem. 2006;17:689–696. doi: 10.1016/j.jnutbio.2005.11.006. [DOI] [PubMed] [Google Scholar]
  • 39.Lee YM, Lim DY, Choi HJ, Jung JI, Chung WY, Park JHY. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin. J Med Food. 2009;12:8–14. doi: 10.1089/jmf.2008.0039. [DOI] [PubMed] [Google Scholar]
  • 40.Kim YM, Kim TH, Kim YW, Yang YM, Ryu DH, Hwang SJ, Lee JR, Kim SC, Kim SG. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition. Free Rad Biol Med. 2010;49:1722–1734. doi: 10.1016/j.freeradbiomed.2010.09.001. [DOI] [PubMed] [Google Scholar]
  • 41.Kim YW, Ki SH, Lee JR, Lee SJ, Kim CW, Kim SC, Kim SG. Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine. Chem Biol Interact. 2006;161:125–138. doi: 10.1016/j.cbi.2006.03.008. [DOI] [PubMed] [Google Scholar]
  • 42.Jang EY, Hwang M, Yoon SS, Lee JR, Kim KJ, Kim HC, Yang CH. Liquiritigenin decreases selective molecular and behavioral effects of cocaine in rodents. Curr Neuropharmacol. 2011;9:30–94. doi: 10.2174/157015911795017371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Jang EY, Choe ES, Hwang M, Kim SC, Lee JR, Kim SG, Jeon JP, Buono RJ, Yang CH. Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABA(B) receptor. Eur J Pharmacol. 2008;587:124–128. doi: 10.1016/j.ejphar.2008.03.054. [DOI] [PubMed] [Google Scholar]
  • 44.Boumendjel A, Ronot X, Boutonnat J. Chalcones derivatives acting as cell cycle blockers: potential anticancer drugs? Curr Drug Targets. 2009;10:363–371. doi: 10.2174/138945009787846416. [DOI] [PubMed] [Google Scholar]
  • 45.Slade D, Ferreira D, Marais JPJ. Circular dichroism, a powerful tool for the assessment of absolute configuration of flavonoids. Phytochemistry. 2005;66:2177–2215. doi: 10.1016/j.phytochem.2005.02.002. [DOI] [PubMed] [Google Scholar]
  • 46.Gaffield W. Circular Dichroism Optical Rotary Dispersion and Absolute Configuration of Flavanones, 3-hydroxyflavanones and their glycosides. Tetrahedron. 1970;26:4093–4108. [Google Scholar]
  • 47.Friesen JB, Pauli GF. Rational development of solvent system families in counter-current chromatography. J Chromatogr A. 2007;1151:51–59. doi: 10.1016/j.chroma.2007.01.126. [DOI] [PubMed] [Google Scholar]
  • 48.Wang Z. Wessely—Moser Rearrangement. Comprehensive Organic Name Reactions and Reagents. Comprehensive Organic Name Reactions and Reagents. 2010:2983–2987. [Google Scholar]
  • 49.Funari CS, Passalacqua TG, Rinaldo D, Napolitano A, Festa M, Capasso A, Piacente S, Pizza C, Young MCM, Durigan G, Silva DHS. Interconverting flavanone glucosides and other phenolic compounds in Lippia salviaefolia Cham. ethanol extracts. Phytochem. 2011;72:2052–2061. doi: 10.1016/j.phytochem.2011.07.004. [DOI] [PubMed] [Google Scholar]
  • 50.Caccamese S, Chillemi R. Racemization at C-2 of naringin in pummelo (Citrus grandis) with increasing maturity determined by chiral high-performance liquid chromatography. J Chromatogr A. 2010;1217:1089–1093. doi: 10.1016/j.chroma.2009.10.073. [DOI] [PubMed] [Google Scholar]
  • 51.Pauli GF, Chen SN, Friesen JB, McAlpine JB, Jaki BU. Analysis and Purification of Bioactive Natural Products: The AnaPurNa Study. J Nat Prod. 2012;75:1243–1255. doi: 10.1021/np300066q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hintermann L, Dittmer C. Asymmetric Ion-Pairing Catalysis of the Reversible Cyclization of 2′-Hydroxychalcone to Flavanone: Asymmetric Catalysis of an Equilibrating Reaction. Eur J Org Chem. 2012:5573–5584. [Google Scholar]
  • 53.Li C, Homma M, Oka K. Chiral resolution of four major flavanones in post-administrative urine of Chinese herbal medicines by HPLC on macroporous silica gel coated with cellulose tris(3,5-dimethylphenylcarbamate) Biomed Chromatogr. 1998;12:199–202. doi: 10.1002/(SICI)1099-0801(199807/08)12:4<199::AID-BMC735>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  • 54.Sayre CL, Hopkins M, Takemoto JK, Davies NM. Chiral analytical method development of liquiritigenin with application to a pharmacokinetic study. Biomed Chromatogr. 2012 doi: 10.1002/bmc.2853. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wistuba D, Trapp O, Gel-Moreto N, Galensa R, Schurig V. Stereoisomeric separation of flavanones and flavanone-7-O-glycosides by capillary electrophoresis and determination of interconversion barriers. Anal Chem. 2006;78:3424–3433. doi: 10.1021/ac0600499. [DOI] [PubMed] [Google Scholar]
  • 56.Wolff H, Motyl M, Hellerbrand C, Heilmann J, Kraus B. Xanthohumol uptake and intracellular kinetics in hepatocytes, hepatic stellate cells, and intestinal cells. J Agric Food Chem. 2011;59:12893–12901. doi: 10.1021/jf203689z. [DOI] [PubMed] [Google Scholar]
  • 57.Gil-Izquierdo A, Gil MI, Tomas-Barberan FA, Ferreres F. Influence of industrial processing on orange juice flavanone solubility and transformation to chalcones under gastrointestinal conditions. J Agric Food Chem. 2003;51:3024–3028. doi: 10.1021/jf020986r. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES